Biotechnology & Life Sciences Global On demand · 24-48h

Global Instrumentation for Soil Microbial DNA Analysis Market Strategic Research Report

Global Instrumentation for Soil Microbial DNA Analysis Marke…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Instrumentation for Soil Microbial DNA Analysis Market
$3332025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Sample Preparation & Nucleic Acid Extraction Instrument, Target Amplification & Enrichment Instrument, DNA Sequencing Instrument

By Application: Precision Agriculture, Environmental Monitoring, Ecological Restoration, Biotechnology Research, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Qiagen N.V. (NYSE: QGEN, Venlo Netherlands), Agilent Technologies, Inc. (NYSE: A, California USA), Merck KGaA (ETR: MRK, Darmstadt Germany), Bio-Rad Laboratories, Inc. (NYSE: BIO, California USA), Oxford Nanopore Technologies plc (LSE: ONT, Oxford UK), Pacific Biosciences of California, Inc. (NASDAQ: PACB, California USA), PerkinElmer, Inc. (NYSE: PKI, Massachusetts USA), Tecan Group Ltd. (SIX: TECN, Männedorf Switzerland), MGI Tech Co., Ltd. (SSE: 688114, Shenzhen China), Berry Genomics Co., Ltd. (SZSE: 000710, Beijing China), Shanghai Zybio Inc. (SSE: 688317, Shanghai China), Sansure Biotech Inc. (SSE: 688289, Changsha China), Bioer Technology Co., Ltd. (Unlisted, Hangzhou China), Shenzhen Genomix Biotechnology Co., Ltd. (Unlisted, Shenzhen China), Beijing Qitan Technology Co., Ltd. (Unlisted, Beijing China)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 140 pages
Market size 2025
$333
Million USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$474.8
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Instrumentation for Soil Microbial DNA Analysis market size is predicted to grow from US$ 333 million in 2025 to US$ 472 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Instrumentation for soil microbial DNA analysis refers to a series of specialized device used to extract, amplify, sequence, and analyze total microbial DNA from soil samples. Their core function is to transform the complex and invisible microbial communities in soil into quantifiable and interpretable gene sequence data, thereby solving the fundamental problem that traditional culture methods cannot detect the vast majority of soil microorganisms and cannot reveal their species composition and functional potential in high-throughput. Upstream suppliers are key components and raw material suppliers, including manufacturers of precision optics, semiconductor chips, high-precision fluid control systems, special enzymes, and biochemical reagents, providing the "heart" and "blood" for instrument manufacturing. Downstream services directly serve end users and the market, mainly including: 1. Research institutions (universities and research institutes, for basic discovery); 2. Commercial testing laboratories (providing soil health diagnostic services); 3. Large agricultural enterprises and breeding companies (for R&D and quality control). In 2025, the production volume of instrumentation for soil microbial DNA analysis is estimated at approximately 68,000 units, with an average price of approximately US$5,000 per unit, a gross profit margin of approximately 45%, and a single-line production capacity of approximately 800 units per year.

Global key Instrumentation for Soil Microbial DNA Analysis players cover Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Qiagen N.V. (NYSE: QGEN, Venlo Netherlands), Agilent Technologies, Inc. (NYSE: A, California USA), Merck KGaA (ETR: MRK, Darmstadt Germany), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Instrumentation for Soil Microbial DNA Analysis market?

What factors are driving Instrumentation for Soil Microbial DNA Analysis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Instrumentation for Soil Microbial DNA Analysis market opportunities vary by end market size?

How does Instrumentation for Soil Microbial DNA Analysis break out by Type, by Application?

This report presents a comprehensive overview of the global Instrumentation for Soil Microbial DNA Analysis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Sample Preparation & Nucleic Acid Extraction Instrument
  • Target Amplification & Enrichment Instrument
  • DNA Sequencing Instrument

Segment by Instrument Deployment

  • Fixed Testing Instrument
  • Portable Testing Instrument

Segment by Application

  • Precision Agriculture
  • Environmental Monitoring
  • Ecological Restoration
  • Biotechnology Research
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Instrumentation for Soil Microbial DNA Analysis market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Precision Agriculture, Environmental Monitoring, Ecological Restoration evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Instrumentation for Soil Microbial DNA Analysis Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$333
2025
Forecast
$474.8
2032
CAGR
5.2%
2025–2032
Regiões
5
global
Key companies
IlluminaInc. (NASDAQ: ILMNCalifornia USA)Thermo Fisher Scientific Inc. (NYSE: TMOMassachusetts USA)Qiagen N.V. (NYSE: QGENVenlo Netherlands)Agilent Technologies
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Sample Preparation & Nucleic Acid Extraction InstrumentTarget Amplification & Enrichment InstrumentDNA Sequencing Instrument
By Application
Precision AgricultureEnvironmental MonitoringEcological RestorationBiotechnology ResearchOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Sample Preparation & Nucleic Acid Extraction Instrument
  • 3.1.3 Target Amplification & Enrichment Instrument
  • 3.1.4 DNA Sequencing Instrument
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Precision Agriculture
  • 4.1.3 Environmental Monitoring
  • 4.1.4 Ecological Restoration
  • 4.1.5 Biotechnology Research
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Illumina, Inc. (NASDAQ: ILMN, California USA)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Qiagen N.V. (NYSE: QGEN, Venlo Netherlands)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Agilent Technologies, Inc. (NYSE: A, California USA)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Merck KGaA (ETR: MRK, Darmstadt Germany)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bio-Rad Laboratories, Inc. (NYSE: BIO, California USA)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Oxford Nanopore Technologies plc (LSE: ONT, Oxford UK)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pacific Biosciences of California, Inc. (NASDAQ: PACB, California USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 PerkinElmer, Inc. (NYSE: PKI, Massachusetts USA)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Tecan Group Ltd. (SIX: TECN, Männedorf Switzerland)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 MGI Tech Co., Ltd. (SSE: 688114, Shenzhen China)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Berry Genomics Co., Ltd. (SZSE: 000710, Beijing China)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shanghai Zybio Inc. (SSE: 688317, Shanghai China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Sansure Biotech Inc. (SSE: 688289, Changsha China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Bioer Technology Co., Ltd. (Unlisted, Hangzhou China)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shenzhen Genomix Biotechnology Co., Ltd. (Unlisted, Shenzhen China)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Beijing Qitan Technology Co., Ltd. (Unlisted, Beijing China)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Instrumentation for Soil Microbial DNA Analysis market?
The global Instrumentation for Soil Microbial DNA Analysis market is estimated at US$ 333 million in 2025 (base year) and is projected to reach US$ 472 million by 2032.
How fast is the Instrumentation for Soil Microbial DNA Analysis market expected to grow?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 333 million in 2025 to US$ 472 million in 2032, roughly 1.4 times its base-year value.
What does the Instrumentation for Soil Microbial DNA Analysis market cover?
Instrumentation for soil microbial DNA analysis refers to a series of specialized device used to extract, amplify, sequence, and analyze total microbial DNA from soil samples. Their core function is to transform the complex and invisible microbial communities in soil into quantifiable and interpretable gene sequence data, thereby solving the fundamental problem that traditional culture methods cannot detect the vast majority of soil microorganisms and cannot reveal their species composition and functional potential in high-throughput.
How is the Instrumentation for Soil Microbial DNA Analysis market segmented by type?
By type, the market is segmented into Sample Preparation & Nucleic Acid Extraction Instrument, Target Amplification & Enrichment Instrument and DNA Sequencing Instrument.
What are the key applications of Instrumentation for Soil Microbial DNA Analysis?
Key applications covered include Precision Agriculture, Environmental Monitoring, Ecological Restoration, Biotechnology Research and Other.
Which companies are profiled in the Instrumentation for Soil Microbial DNA Analysis market report?
Key players profiled include Illumina, Inc. (NASDAQ: ILMN, California USA), Thermo Fisher Scientific Inc. (NYSE: TMO, Massachusetts USA), Qiagen N.V. (NYSE: QGEN, Venlo Netherlands), Agilent Technologies, Inc. (NYSE: A, California USA), Merck KGaA (ETR: MRK, Darmstadt Germany), Bio-Rad Laboratories, Inc. (NYSE: BIO, California USA), Oxford Nanopore Technologies plc (LSE: ONT, Oxford UK) and Pacific Biosciences of California, Inc. (NASDAQ: PACB, California USA), among 17 companies covered in total.
What geographies does the Instrumentation for Soil Microbial DNA Analysis market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Instrumentation for Soil Microbial DNA Analysis?
What factors are driving Instrumentation for Soil Microbial DNA Analysis market growth, globally and by region?
Who should buy the Instrumentation for Soil Microbial DNA Analysis market report?
The report is intended for manufacturers and solution providers, distributors and end users in Precision Agriculture, Environmental Monitoring and Ecological Restoration, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Instrumentation for Soil Microbial DNA Analysis market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.